Sarah Schlesinger

Institutional Career Development Core

National Center for Advancing Translational Sciences · KL2

Contact PI · $5.1M · Rockefeller University

A New Anti-CD27 Monoclonal Antibody Adjuvant for Pancreatic Cancer Vaccines

National Institute of Allergy and Infectious Diseases · R21

Contact PI · $466.1K · Rockefeller University

Identification and Vaccine Adjuvant Responses of Dendritic Cells in Humans

National Institute of Allergy and Infectious Diseases · R56

Contact PI · $519.9K · Rockefeller University

Integrating Innate and Adaptive Pathways in Vaccine Responses

National Institute of Allergy and Infectious Diseases · U19

Project lead · $2.7M · Rockefeller University

A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR

Principal investigator · Completed · Phase 1

Rockefeller University

DCVax Plus Poly ICLC in Healthy Volunteers

Principal investigator · Completed · Phase 1

Rockefeller University

A Single-Patient Study Using AGS 006

Principal investigator · Completed

Argos Therapeutics